Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002266464 | SCV002548500 | uncertain significance | not specified | 2022-05-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496205 | SCV002792802 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2021-07-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003101506 | SCV003581899 | uncertain significance | Inborn genetic diseases | 2021-10-22 | criteria provided, single submitter | clinical testing | The c.2458G>A (p.A820T) alteration is located in exon 20 (coding exon 18) of the IFT140 gene. This alteration results from a G to A substitution at nucleotide position 2458, causing the alanine (A) at amino acid position 820 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |